"Neurologists at Baylor Medicine specialize in understanding the origin of a disorder and address that disorder with compassion, medical excellence and the latest research-backed therapies. In addition to offering general neurology services, Baylor Medicine neurologists oversee the diagnosis and treatment of specific neurological conditions. We have programs and clinics dedicated to specific conditions and disorders including: - Alzheimer's disease and memory disorders - Epilepsy - Multiple sclerosis - Neuromuscular disease - Neuropsychology - Parkinson's disease and movement disorders"

During the past decade, Baylor College of Medicine Department of Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor College of Medicine Department of Neurology" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine Department of Neurology" are "Parkinson's Disease" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Baylor College of Medicine Department of Neurology" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine Department of Neurology" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "ACC-001 10 μg/ QS-21 50 μg" (1 trials), "ACC-001 3 μg/ QS-21 50 μg" (1 trials), "Placebo -AP-CD/LD" (1 trials) and "Placebo- Phosphate buffered saline (PBS)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine Department of Neurology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Baylor College of Medicine Department of Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Baylor College of Medicine Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine Department of Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".